Find Academic Supervisors

Mattias EkstedtView profile

Assistant Professor

• Fatty Liver Disease
• Medical Education
• Cardiovascular Disease
• +5 more

Mattias Ekstedt is an Assistant Professor at Linköping University's Department of Health, Medicine and Care (HMV), Faculty of Medicine. As a Senior Physician and Docent in Gastroenterology and Hepatology, his work focuses on improving fatty liver disease diagnostics and patient quality of life through innovative techniques. Medical Degree (2003) PhD (2008) Specialist in Internal Medicine (2011) Docent in Gastroenterology (2020) Ekstedt leads research on metabolic dysfunction-associated steatotic liver disease (MASLD) and its cardiovascular links, co-supervising 15+ doctoral students. His projects include DETECT-HCC-ESLD (non-invasive liver cancer detection), EPSOMiP (epicardial fat and diabetes), and ACCESS (muscle degeneration prediction). He founded the Research Network for Studies of Ectopic Fat Storage and serves in organizations like the Gastrointestinal Foundation and EASL International Liver Foundation. Recent publications emphasize non-invasive diagnostics, proteomic biomarkers, and MASLD's systemic implications. Awards include the 2013 STINT Scholarship for teaching excellence and Educator of the Year 2015. Ekstedt actively develops medical education through MEQ exams, OSCE, and digital teaching frameworks.

• Cardiology
• Internal Medicine
• Metabolic Health
• +3 more

Nadia Bouabdallaoui is a Clinical Assistant Professor at the Department of Medicine within the Faculty of Medicine at Université de Montréal . Her academic profile focuses on clinical research in cardiology, particularly in heart failure and metabolic health. Primary Affiliation: Université de Montréal, Faculty of Medicine Academic Role: Clinical Assistant Professor Department: Department of Medicine Email: nadia.bouabdallaoui@umontreal.ca Dr. Bouabdallaoui's research explores inflammatory mechanisms in heart failure with preserved ejection fraction (HFpEF) , colchicine therapy applications , and metabolic interventions for diabetes remission . She leads projects investigating myocardial dysfunction and inflammation modulation through pharmacological and lifestyle approaches. Her recent work includes clinical trials like: (1) Personalized myocardial dysfunction approach in HFpEF (2023), (2) COLpEF phase 2 trial on colchicine effects in HF (2022), and (3) COLCOT-T2D for cardiovascular prevention in diabetes patients (2020). These studies demonstrate her focus on anti-inflammatory therapies and metabolic-cardiac interactions . She supervises graduate research, including Josep Iglesias Grau's 2023 Master's thesis on metabolic health improvement through lifestyle changes . Her research receives funding from FRQS (Fonds de recherche du Québec - Santé) and CIHR (Canadian Institutes of Health Research) through project grants and network funding. Dr. Bouabdallaoui collaborates with multidisciplinary teams including cardiology experts like Jean-Claude Tardif, Martin Sirois, and the Canadian Heart Failure Transformation Alliance members. Her work bridges clinical practice with translational research in cardiovascular medicine.

• Parkinson's Disease Research
• Neuroimmunology
• Neurobiology
• +1 more

Kala Venkiteswaran, PhD is an Associate Professor at the University of Toledo in the Department of Neurology since 2021. His research focuses on Parkinson's Disease , with emphasis on gut-brain axis interactions and neuroimmunology . He holds memberships in prominent societies including the Parkinson's Study Group , International Parkinson and Movement Disorder Society , and Society for Neuroscience . BSc , University of Calicut MSc , Cochin University of Science and Technology PhD , University of Calicut His work spans neurodegeneration , cell transplantation , and neuropharmacology , with key contributions to REM sleep disorders , levodopa dosing , and Mucuna pruriens therapy. Venkiteswaran has served as a manuscript reviewer for journals like Brain Research and npj Parkinson's Disease , and contributed to book chapters on early Parkinson's management and neuroimaging . Venkiteswaran's research explores environmental toxin-induced Parkinsonism , immunological barriers for cell therapies, and genetic modulation of neural circuits. His publications highlight collaborations with the Parkinson Study Group and interdisciplinary focus on neuroinflammation and synaptic repair . Contact: neurology@utoledo.edu | Academic Office : 419.291.0396

• Trauma Surgery
• Hematology
• Critical Care Medicine
• +5 more

Lucy Zumwinkle Kornblith, MD, FACS is an Associate Professor of Surgery at the University of California San Francisco (UCSF) School of Medicine, where she serves as Director of Research at Zuckerberg San Francisco General Hospital. She holds the Elsbach-Richards Endowed Chair in Surgery I and practices clinically in Trauma Surgery, Acute Care Surgery, and Surgical Critical Care. Education : BS in Biological Sciences (UC Santa Barbara), MD (University of Colorado), General Surgery Residency (UCSF), Trauma & Critical Care Fellowship (UCSF) Board Certifications : American Board of Surgery (Surgery, Surgical Critical Care) Her research program focuses on trauma-induced coagulopathy , post-injury platelet biology , and hemorrhage resuscitation strategies . She employs translational research to identify novel blood system failure mechanisms, large observational studies to predict post-trauma complications, and multicenter clinical trials to evaluate therapeutic interventions. Article Trends : 2025 studies highlight her work on interferon-γ dynamics , platelet-virus interactions , and coagulation biomarkers . 2024 publications emphasize SGLT2 inhibitor effects , CLOTT-1 registry analyses , and endotheliopathy mechanisms . Earlier works establish her expertise in trauma thromboembolism , platelet transcriptomics , and gender disparities in trauma care . Scientific Awards include the American College of Surgeons' George H.A. Clowes Award, multiple Eastern Association for the Surgery of Trauma scholarships, and UCSF's Irene Perstein Award. As a mentor , she trains translational researchers across career stages, serves as a CTSI Mentor of the Year, and contributes to UC Berkeley dissertation committees . Her laboratory at Zuckerberg San Francisco General Hospital leads platelet biology and trauma coagulopathy research, with funding from NIH, DoD, and Doris Duke Charitable Foundation.

Emma DavenportView profile

Professor

• Functional Genomics
• Clinical Data Integration
• Genetic Variation in Disease Response
• +7 more

Dr. Emma Davenport is a Group Leader at the Wellcome Sanger Institute within the Human Genetics Programme, where she leads the Davenport Group focused on Functional Genomics of Variation in Disease Response. She joined the Sanger Institute in October 2018 after completing postdoctoral research at Harvard Medical School in Professor Soumya Raychaudhuri's lab at Brigham and Women's Hospital and the Broad Institute. Her research integrates functional genomics and clinical data to understand how genetics contributes to patient-to-patient heterogeneity in disease severity and treatment response. Dr. Davenport's primary research interests focus on diseases involving systemic inflammation such as sepsis and systemic lupus erythematosus (SLE). Her work employs sophisticated analytical methods to analyze functional genomics data from hundreds of patient cohorts, integrating this with clinical information. She specializes in transcriptomic profiling to stratify patients and understand individual responses to infections and autoimmune conditions. Her group investigates expression quantitative trait locus (eQTL) interactions to uncover how environmental factors modulate genetic regulatory effects on gene expression. Analysis of Dr. Davenport's publication record reveals a strong focus on patient stratification through transcriptomic signatures, particularly in sepsis where her group identified the Sepsis Response Signature (SRS) endotypes. Her research spans multiple areas including host-pathogen interactions, drug response variability, and single-cell eQTL mapping in autoimmune diseases. Recent work has expanded into multi-omics approaches, integrating genomic, transcriptomic, and proteomic data to understand the molecular basis of disease heterogeneity. Dr. Davenport has successfully mentored numerous PhD students and postdoctoral fellows who have contributed significantly to her research program. Her group collaborates extensively with clinical partners through initiatives like the Genomics Advances in Sepsis (GAinS) study and the Bioresource for Adult Infectious Diseases (BioAID), applying genomic approaches to improve diagnosis and treatment of infectious diseases.

Prasad VG KatakamView profile

Professor

• Cerebral microcirculation
• Stroke
• Diabetes
• +4 more

Prasad VG Katakam, MD PhD, is a tenured Professor in the Department of Pharmacology at Tulane University School of Medicine. His research focuses on cerebrovascular dysfunction in insulin resistance and diabetes, with a particular interest in cerebral microcirculation, stroke, aging, and Alzheimer’s disease. Education: MBBS (Andhra University, 1989), MS in Pharmacology (University of Georgia, 1995), MD (ECFMG, 1995), PhD in Pharmacology (University of Georgia, 1999) His work explores how mitochondrial bioenergetics, free radicals, and nitric oxide synthase isoforms regulate brain microvascular function and blood-brain barrier integrity. Techniques include isolated artery preparations, laser confocal microscopy, two-photon excitation microscopy, and Seahorse Extracellular Flux Analyzer for mitochondrial studies.

Ning LiuView profile

Assistant Professor

• Molecular Neuroscience
• Neuroinflammation
• Traumatic Brain Injury (TBI)
• +4 more

Dr. Ning Liu is an Assistant Professor of Neurosurgery and Neurology at Tulane University School of Medicine, affiliated with the Clinical Neuroscience Research Center. His research focuses on molecular mechanisms and therapeutic strategies for acute brain injuries, including cerebral ischemia and traumatic brain injury (TBI). PhD: Biochemistry and Molecular Biology, Hunan Normal University, China Postdoctoral Research Fellow: Neuroprotection Research Laboratory, Massachusetts General Hospital/Harvard Medical School (2014–2019) Dr. Liu’s work bridges molecular neuroscience and translational stroke research, with expertise in mitochondrial metabolism, in vivo brain injury models, and neuroinflammatory pathways. His recent publications highlight: T cell and microglial contributions to post-injury neuroinflammation Mitochondrial unfolded protein response (UPRmt) in neuroprotection Therapeutic interventions for blood-brain barrier integrity and metabolic dysfunction He continues to advance acute brain injury research at Tulane University’s Clinical Neuroscience Research Center.

• Cardiology
• Vascular Diseases
• Pulmonary Medicine
• +7 more

Arang Samim, MD, is an Assistant Clinical Professor in the Cardiology department at the School of Medicine, University of California, San Francisco (UCSF) . He is affiliated with the Fresno Medical Education Program (MEP) , where he specializes in interventional cardiology and cardiovascular disease. Education : BA in Chemistry and Biology from Boston University (2002) MA in Medical Sciences from Boston University (2004) MD from Boston University School of Medicine (2008) Internal Medicine Residency at Cedars-Sinai Medical Center (2011) Cardiovascular Disease Fellowship at UCSF Fresno MEP (2015) Interventional Cardiology Fellowship at UCSF Fresno MEP (2016) Dr. Samim’s research focuses on cardiovascular disease , with expertise in myocardial ischemia , heart failure , vascular complications , and interventional cardiology . His publications highlight work in CT imaging , pleural effusion risk factors , and iatrogenic injuries . He has also contributed to otolaryngology literature on biopsy techniques for laryngopharyngeal tumors. His recent publications (2010–2024) span topics from fibromuscular dysplasia and myocardial viability to cost-effectiveness in head and neck surgery . NLM-classified fields include Cardiology , Vascular Diseases , Pulmonary Medicine , Radiology , and Otolaryngology .

Kang I KoView profile

Assistant Professor

• Oral Biology
• Immunology
• Wound Healing
• +6 more

Kang I Ko, DMD, DScD, is an Assistant Professor in the Department of Periodontics at Penn Dental Medicine. He holds dual degrees in Physiology/Neuroscience and Neurobiology from UC San Diego, followed by clinical and research training at Penn Dental Medicine where he completed a combined Periodontics certificate/D.ScD program. Undergraduate: BS in Physiology & Neuroscience (2009) Graduate: MS in Neurobiology (2011) Dental: DMD (2015), DScD in Stem Cell Biology (2020) Dr. Ko's research focuses on fibroblast heterogeneity and its immunomodulatory effects in oral and cutaneous inflammation. His work explores diabetes-related mucosal wound healing, periodontitis pathogenesis, and epigenetic interventions for regenerative medicine. Current projects include NIH-funded studies on cellular interactions in inflammatory microenvironments. The 15 most recent publications reveal concentrated research directions in: Single-cell profiling of inflammatory diseases Epithelial-fibroblast interactions in mucosal healing Diabetes-induced immunomodulatory disruptions Ferroptosis in periodontal inflammation Epigenetic regulation of wound repair Scientific recognition includes: Ricardo Teles Research Award (2020) NIH Loan Repayment Program (2020) K08 Career Development Award (2017) Multiple AADR travel grants and specialty awards Dr. Ko maintains active membership in major professional organizations including the American Academy of Periodontology and International Association for Dental Research. His clinical work in periodontics complements his laboratory research on tissue-specific inflammatory responses.

Hamit YildizView profile

Associate Professor

• Internal Medicine
• Diabetes
• Sepsis
• +4 more

Associate Professor Hamit Yildiz is affiliated with Gaziantep University Faculty of Medicine, Department of Internal Medicine. With a medical specialization from 2012-2016 at Gaziantep University, he has focused on diabetes, sepsis, and intensive care medicine. Medical License: 2004-2011, Gaziantep University Academic Rank: Associate Professor since 2020 Editorial Roles: Associate Editor for Experimental and Applied Medical Science (2022), Ortadoğu Medical Journal (2019), and others His research spans diabetes , sepsis , and intensive care medicine , with recent studies on metabolic disorders, thiol/disulfide homeostasis, and sepsis biomarkers. Articles analyze dietary acid load in diabetics, taste function factors , and monoclonal antibody production . Key projects include TÜBİTAK-funded work on bleomycin-induced pulmonary fibrosis and nutrition in sepsis molecular pathways . Scientific Contributions: 11 Books/Book Chapters 37 Original Articles 5 National Research Projects (2019-2023) Key Collaborations: Co-authored with researchers on diabetes, sepsis, and rheumatology topics He has supervised medical specialty theses on miRNA changes in diabetic nephropathy , nutrition in sepsis , and sepsis biomarkers . His editorial roles include journals such as Experimental and Applied Medical Science and Ortadoğu Medical Journal . No specific scientific awards are mentioned.

• Cardiovascular Medicine
• Antiplatelet Therapy
• Cardiology
• +4 more

Mattia Galli is a Researcher at the Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome. He teaches courses including Cardiovascular Instrumental Diagnostics, Human Anatomy, and Clinical Nursing in Cardiovascular Disease. His academic work focuses on cardiovascular medicine and biotechnologies with a strong emphasis on clinical applications. Dr. Galli's research spans multiple areas of cardiovascular medicine with particular expertise in: Antiplatelet and anticoagulant therapies Percutaneous coronary interventions Cardiovascular pharmacology Thrombosis and bleeding risk management Personalized medicine approaches in cardiology Platelet function and genetic testing His recent publications (2023-2024) demonstrate a strong focus on optimizing antiplatelet therapy, particularly examining factors like genetic variations, renal function, and ethnic differences that affect treatment response. His work often involves meta-analyses and clinical trials, including several SWAP studies examining therapy switching protocols and the TAPER-S study on ischemic preconditioning. He has made significant contributions to understanding high bleeding risk scenarios, aspirin hypersensitivity, and dual pathway inhibition strategies. Dr. Galli's research bridges the gap between pharmacological mechanisms and clinical practice, aiming to improve patient outcomes through evidence-based approaches. His work has appeared in top-tier journals including European Heart Journal, JACC, and Nature Reviews Cardiology, reflecting the high impact of his contributions to the field of cardiovascular medicine.

Süha ÇetinView profile

Associate Professor

• Cardiology
• Interventional Cardiology
• Echocardiography
• +4 more

Prof. Dr. Süha Çetin is an Associate Professor and interventional cardiologist at Okan University Hospital in Istanbul, where he has served in the Department of Cardiology since 2016. Fluent in German and English, he specializes in advanced cardiac imaging and interventional procedures, with clinical expertise developed through training at Ulm University and institutions in North America and the UK. Education Medical Education: University of Tübingen, Germany Cardiology Specialist Training: University of Ulm, Germany Cardiology Education: Ohio, North America Interventional Cardiology Training: Bristol Heart Institute and Leicester Royal Infirmary, UK Research Interests His research centers on cardiovascular pathophysiology in sleep disorders, particularly obstructive sleep apnea's impact on cardiac structure and function. He employs advanced echocardiographic techniques including speckle tracking to investigate left atrial/ventricular remodeling, coronary microvascular dysfunction in diabetes, and cardiotoxicity in cancer survivors. His work bridges clinical cardiology with metabolic and autoimmune conditions. Publication Trends Analysis of his 15 most recent publications (2014-2024) reveals persistent focus on sleep apnea-cardiac interactions (37% of works), with secondary themes in diabetic coronary disease (13%), cardio-oncology (7%), and stroke-related cardiac mechanisms (13%). Over 60% utilize echocardiography innovations, demonstrating his methodological specialization in strain imaging and functional assessment. Recurring co-authors indicate established collaborations with Vural MG and Heper G across multiple studies.

Teresa Sanchez Garcia VaoView profile

Associate Professor

• Vascular Biology
• Neurovascular Signaling
• Cerebral Microvasculature
• +5 more

Teresa Sanchez Garcia Vao is an Associate Professor of Neuroscience at the Brain and Mind Research Institute and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College, where she also serves as Principal Investigator and head of the Laboratory of Molecular and Translational Vascular Research. Her work bridges vascular biology, neuroscience, and stroke research with significant contributions to understanding cerebrovascular mechanisms in neurological disorders. Her educational background includes a Pharm.B. (1996), M.S. (1997), and Ph.D. (2001), all from the University of Barcelona. Pharm.B., University of Barcelona (1996) M.S., University of Barcelona (1997) Ph.D., University of Barcelona (2001) Dr. Sanchez Garcia Vao's research focuses on cerebral microvasculature dynamics in neurodegenerative and cerebrovascular diseases, with particular emphasis on sphingosine-1-phosphate signaling pathways. Her work reveals critical mechanisms in sepsis-associated cognitive dysfunction, Alzheimer's-related capillary stalling, and stroke-induced vascular damage. Current investigations explore therapeutic targeting of vascular oxidative stress, neutrophil-endothelial interactions, and blood-brain barrier modulation using advanced molecular and preclinical approaches. Analysis of her 15 most recent publications shows a consistent trajectory in neurovascular signaling , with increasing focus on translational applications for dementia and stroke. Key themes include S1P receptor modulation (S1PR1/S1PR2), cerebral blood flow regulation, and microvascular contributions to cognitive impairment across diverse disease models from sepsis to Alzheimer's pathology. Her scientific recognition includes: Florence Gould Foundation Research Scholar for Discovery in Stroke (2024) Dr. Sanchez Garcia Vao leads multiple major research initiatives including the AHA-funded project Unraveling Mechanisms in Cerebral Microvascular Dysfunction (2025-2030) and the Alzheimer's Association study on Therapeutic Targeting of Cerebral Microvasculature in Dementia (2025-2028). She also directs the NINDS-supported investigation of Endothelial Sphingolipid Signaling in Neurovascular Injury (2020-2026) and co-leads research on capillary stalling in Alzheimer's disease. Principal Investigator: AHA project on microvascular dysfunction (2025-2030) Principal Investigator: Alzheimer's Association dementia project (2025-2028) Principal Investigator: NINDS sphingolipid signaling study (2020-2026) Co-Principal Investigator: Capillary stalling in Alzheimer's project She directs the Laboratory of Molecular and Translational Vascular Research, which develops innovative methodologies for cerebral microvessel isolation and characterization while investigating therapeutic strategies for vascular-mediated cognitive impairment through interdisciplinary approaches integrating molecular biology, neuroimaging, and preclinical disease modeling.

Adviye ErgulView profile

Professor

• Vascular complications of diabetes and hypertension
• Acute ischemic stroke
• Alzheimer's Disease Related Deteriorias
• +5 more

Adviye Ergul is a Professor at the Medical University of South Carolina in the Department of Pathology and Laboratory Medicine. She holds secondary appointments at Augusta University and the Charlie Norwood VA Medical Center. Her research focuses on vascular complications of diabetes and hypertension, acute ischemic stroke, and Alzheimer's disease-related dementias, with specific emphasis on endothelial cell biology and vascular pathology. Education : MD from Cerrahpasa Medical School (Istanbul, Turkey, 1987), PhD in Biochemistry & Molecular Biology from University of Miami School of Medicine (1995), postdoctoral training in Vascular Biology at University of Georgia. Her work explores mechanisms of endothelin system dysfunction , microvascular senescence , and inflammatory pathways in diabetic and hypertensive conditions. Recent studies investigate novel therapies like angiotensin receptor agonists and iron chelation for post-stroke cognitive impairment. She has published extensively on diabetes-stroke interactions , endothelin signaling , and sex differences in vascular disease. Key research trends include neurovascular unit remodeling , microemboli-mediated dementia , and mitochondrial quality control in brain injury. Her laboratory developed diabetic stroke models to test interventions like linagliptin and bosentan . Awards : NIH Individual Research Service Award, American Heart Association Scientist Development Award, Veterans Administration Research Career Scientist, Regents’ Professorship, Phi Kappa Phi Honor Society.

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes
• +3 more

Jacob Thomsen Lønborg serves as a Clinical Associate Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. His clinical and research work is closely affiliated with Region Hovedstaden (Capital Region of Denmark) where he practices at the address Blegdamsvej 3, 2200 København N. His academic career focuses on interventional cardiology with particular expertise in acute coronary syndromes and complex revascularization strategies. Dr. Lønborg's research interests center on interventional cardiology , specifically examining optimal treatment approaches for ST-elevation myocardial infarction (STEMI) patients with multivessel disease. His work investigates long-term outcomes of different revascularization strategies, the impact of novel pharmacotherapies on cardiovascular outcomes, and advanced imaging techniques to assess vascular inflammation. He has made significant contributions to understanding cardiogenic shock management and microvascular dysfunction following myocardial infarction. His publication record demonstrates a strong focus on large-scale clinical trials, particularly the DANAMI-3 program (PRIMULTI and DEFER studies) and the DanGer Shock substudy. These works have received substantial attention in the medical community, with several papers being referenced in clinical guidelines and picked up by numerous news outlets. His research has been published in top-tier journals including the New England Journal of Medicine , Journal of the American College of Cardiology , and Circulation . Dr. Lønborg actively collaborates with leading cardiovascular researchers across Denmark and internationally, contributing to multi-center clinical trials that shape contemporary cardiology practice. His work bridges clinical practice with academic research, translating findings into improved patient care for those suffering from acute coronary syndromes and related complications.